September 9, 2002
The First Committee on Drugs of Korosho's CDFS recommended on August 30 the regulatory approval of telmisartan (Micardis Capsule 20mg and two other brand names), a hypertensive agent from Nippon Boehringer Ingelheim, and brinzolamide (Azopt 1% Ophthalmic Suspension), a drug...read more